Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenxbio (RGNX) Interest Expenses (2021 - 2025)

Historic Interest Expenses for Regenxbio (RGNX) over the last 7 years, with Q3 2025 value amounting to $13.2 million.

  • Regenxbio's Interest Expenses rose 150597.56% to $13.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.1 million, marking a year-over-year increase of 81528.77%. This contributed to the annual value of $12.7 million for FY2024, which is 8447.97% up from last year.
  • Latest data reveals that Regenxbio reported Interest Expenses of $13.2 million as of Q3 2025, which was up 150597.56% from $11.0 million recorded in Q2 2025.
  • Regenxbio's 5-year Interest Expenses high stood at $13.2 million for Q3 2025, and its period low was $449000.0 during Q2 2024.
  • For the 5-year period, Regenxbio's Interest Expenses averaged around $5.4 million, with its median value being $6.1 million (2022).
  • Per our database at Business Quant, Regenxbio's Interest Expenses crashed by 8367.35% in 2023 and then skyrocketed by 234832.96% in 2025.
  • Quarter analysis of 5 years shows Regenxbio's Interest Expenses stood at $6.5 million in 2021, then plummeted by 33.69% to $4.3 million in 2022, then plummeted by 68.38% to $1.4 million in 2023, then skyrocketed by 590.9% to $9.4 million in 2024, then skyrocketed by 39.84% to $13.2 million in 2025.
  • Its Interest Expenses was $13.2 million in Q3 2025, compared to $11.0 million in Q2 2025 and $8.6 million in Q1 2025.